Reprinted from the COURAGEOUS DISCOURSE - BREAKING Publication--COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1

Mead et al Deliver Counter-Punch after Springer Nature Unethical Retraction of High-Impact Paper

PETER A. MCCULLOUGH, MD, MPH

JUL 08, 2024

By Peter A. McCullough, MD, MPH

Every major development in medicine evolves over years with peer-reviewed manuscripts and published correspondence along the lines of arguments and scientific discourse. Never had we seen a new technology and mass mandated line of medical products be introduced with no allowance for proper scientific discourse. Not until mRNA.

Mead and co-workers found themselves at the center of a controversy when Springer Nature CUREUS Journal of Biomedical Sciences retracted their paper calling for global market withdrawal of mRNA vaccines. The retraction violated the COPE (Committee on Publication Ethics Guidelines) for retraction and became a news story garnering even more attention. Other papers continued to cite Mead creating a stinging reverberation for Springer who was hoping to silence the paper.

Now epidemiologist M. Nathaniel Mead and six co-authors have punched back with the manuscript divided into two parts for a greater depth of data and analysis on the safety and theoretical efficacy of modified mRNA COVID-19 vaccines. In Part I, Mead discloses censorship of the first paper by the Bio-Pharmaceutical Complex, a working syndicate that is hell-bent on suppressing any scientific information on COVID-19 side effects.

You may ask what should have occurred? Springer Nature should have never retracted the paper. Rather letters to the editor and responses to the letters from authors should have been published as proper scientific interchange. The new normal is now unethical retraction, massive publicity, and republication with greater amplification of the message—precisely what the Bio-Pharmaceutical Complex is trying to squelch.

Please subscribe to Courageous Discourse as a paying ($5 monthly) or founder member so we can continue to bring you the truth.

Peter A. McCullough, MD, MPH

President, McCullough Foundation

www.mcculloughfnd.org

Mead MN, Seneff S, Wolfinger R, Rose J, Denhaerynck K, Kirsch S, McCullough PA. COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign. Cureus. 2024 Jan 24;16(1):e52876. doi: 10.7759/cureus.52876. Retraction in: Cureus. 2024 Feb 26;16(2):r137. doi: 10.7759/cureus.r137. PMID: 38274635; PMCID: PMC10810638.

COVID-19 Modified mRNA “Vaccines” Part 1: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex. (2024). International Journal of Vaccine Theory, Practice, and Research , 3(1), 1112-1178. https://doi.org/10.56098/fdrasy50

Subscribe to Courageous Discourse™ with Dr. Peter McCullough & John Leake

https://petermcculloughmd.substack.com/p/breaking-publication-covid-19-modified?publication_id=1119676&post_id=146274342&isFreemail=true&r=16ettj&triedRedirect=true